Diabetes Anxiety and Depression Study: A randomised controlled trial of group sessions of cognitive behavioural therapy (CBT) for people with diabetes

A randomised controlled trial of group sessions of cognitive behavioural therapy for people with anxiety and depression following a new diagnosis of diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN32827674

Enrollment

608

Registered

2009-08-27

Start date

2002-09-15

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes type 1 and 2, anxiety and/or depression Nutritional, Metabolic, Endocrine Unspecified diabetes mellitus

Interventions

Diabetic patients whose Hospital Anxiety and Depression Scale (HADS) score indicated anxiety and depression (greater than or equal to 11 on either HADS-A or HADS-D or a total of both scores together (

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. New diagnosis of diabetes (less than 12 months) 2.18 years of age and above, either sex

Exclusion criteria

Exclusion criteria: 1. Patients with a poor understanding of English 2. Patients whose mental health requires immediate referral to a psychiatrist 3. Patients too physically impaired to attend group sessions

Design outcomes

Primary

Measure	Time frame
The difference in glycaemic control 12 months from baseline as measured by HbA1c.	—

Secondary

Measure	Time frame
1. The change in depression and anxiety as measured by HADS 12 months from baseline 2. The change in quality of life as measured by the 36-item short form health survey version 2 (SF-36V2), 12 months from baseline	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026